Market Price

32.75 

-1.53 -4.5%

as of Aug 23 '19

52 Week Range:

32.60 72.96


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. The company also offers Game Read, a product for pain management and rehabilitation of patients recovering from orthopedic surgery or sports-related injuries; GRPro 2.1, a cold and compression therapy system; Med4Elite, a multi-modality therapy unit; ATX Wraps; and various product accessories. In addition, it sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and GAME READY brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 44.68
22.33
23.60
25.16
27.40
growth rate -50.0% 5.7% 6.6% 8.9%
Earnings BIT 94.30
-118.70
-107.10
-38.10
16.20
growth rate -100.0% 0.0% 0.0% 100.0%
Avg.PE 26.15
25.34
growth rate -3.1%
ROA 6.02
4.94
1.08
-18.83
1.95
3.72
2.85
growth rate -17.9% -78.1% -100.0% 100.0% 90.8% -23.4%
ROE 7.42
5.99
1.52
-33.48
3.69
6.84
4.58
growth rate -19.3% -74.6% -100.0% 100.0% 85.4% -33.0%
ROIC 7.10
5.79
1.16
-20.88
3.80
5.24
4.01
growth rate -18.5% -80.0% -100.0% 100.0% 37.9% -23.5%
Cur. Ratio 1.65
1.89
1.92
2.14
1.83
2.98
2.70
growth rate 14.6% 1.6% 11.5% -14.5% 62.8% -9.4%
Quick Ratio 0.64
0.80
1.08
1.12
0.94
1.08
2.02
growth rate 25.0% 35.0% 3.7% -16.1% 14.9% 87.0%
Leverage 1.23
1.19
1.70
1.90
1.88
1.81
1.41
growth rate -3.3% 42.9% 11.8% -1.1% -3.7% -22.1%
Balance Sheet Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 233.90
224.70
188.50
203.00
150.50
growth rate -3.9% -16.1% 7.7% -25.9%
Acct.Payable 168.70
163.20
160.60
171.20
169.90
growth rate -3.3% -1.6% 6.6% -0.8%
Cur.Assets 683.60
676.00
593.50
1,160.70
713.60
growth rate -1.1% -12.2% 95.6% -38.5%
Total Assets 2,517.90
2,000.20
2,071.80
2,195.90
1,833.40
growth rate -20.6% 3.6% 6.0% -16.5%
Cash 149.00
129.50
113.70
219.70
384.50
growth rate -13.1% -12.2% 93.2% 75.0%
Inventory 283.10
303.20
80.70
91.10
121.40
growth rate 7.1% -73.4% 12.9% 33.3%
Cur.Liabilities 356.00
315.20
324.40
389.80
264.30
growth rate -11.5% 2.9% 20.2% -32.2%
Liabilities 1,026.70
944.90
969.30
980.50
536.20
growth rate -8.0% 2.6% 1.2% -45.3%
LT Debt 622.60
578.10
579.00
541.10
247.70
growth rate -7.2% 0.2% -6.6% -54.2%
Equity 1,491.20
1,055.30
1,102.50
1,215.40
1,297.20
growth rate -29.2% 4.5% 10.2% 6.7%
Common Shares 47.00
47.00
47.00
47.00
47.00
47.00
46.00
47.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% -2.1% 2.2%
Cash Flow Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 78.50
70.40
29.10
43.20
49.10
growth rate -10.3% -58.7% 48.5% 13.7%
Cash From OA 147.90
97.60
188.80
144.20
-145.60
growth rate -34.0% 93.4% -23.6% -100.0%
FCF per Share 2.42
0.70
2.96
1.84
-2.51
growth rate -71.1% 322.9% -37.8% -100.0%
FCF 100.00
162.00
175.00
69.00
27.00
159.00
101.00
-194.00
growth rate 62.0% 8.0% -60.6% -60.9% 488.9% -36.5% -100.0%
Income Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 1,672.10
509.00
566.20
611.60
652.30
growth rate -69.6% 11.2% 8.0% 6.7%
Op.Income 94.30
-118.70
-107.10
-38.10
16.20
growth rate -100.0% 0.0% 0.0% 100.0%
IBT 91.20
-168.50
-139.20
-72.20
-18.10
growth rate -100.0% 0.0% 0.0% 0.0%
Net Income 27.10
-426.30
39.80
79.30
57.50
growth rate -100.0% 100.0% 99.3% -27.5%
EPS 3.06
3.28
3.32
0.58
-9.15
0.85
1.69
1.22
growth rate 7.2% 1.2% -82.5% -100.0% 100.0% 98.8% -27.8%
Gross Profit 548.60
257.80
297.20
336.90
390.90
growth rate -53.0% 15.3% 13.4% 16.0%
R&D 16.60
27.60
38.40
38.20
41.80
growth rate 66.3% 39.1% -0.5% 9.4%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 14.00
15.80
14.40
-22.60
-5.20
growth rate 12.9% -8.9% -100.0% 0.0%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 189.20
151.80
150.50
135.00
124.30
growth rate -19.8% -0.9% -10.3% -7.9%
Acct.Payable 176.90
159.20
169.90
148.80
99.40
growth rate -10.0% 6.7% -12.4% -33.2%
Cur.Assets 876.50
737.20
713.60
660.00
572.50
growth rate -15.9% -3.2% -7.5% -13.3%
Total Assets 1,917.40
1,844.50
1,833.40
1,834.00
1,783.40
growth rate -3.8% -0.6% 0.0% -2.8%
Cash 479.60
411.80
384.50
348.30
288.10
growth rate -14.1% -6.6% -9.4% -17.3%
Inventory 107.80
121.20
121.40
129.60
133.90
growth rate 12.4% 0.2% 6.8% 3.3%
Cur.Liabilities 352.80
265.50
264.30
238.40
187.00
growth rate -24.7% -0.5% -9.8% -21.6%
Liabilities 630.80
544.30
536.20
553.90
506.50
growth rate -13.7% -1.5% 3.3% -8.6%
LT Debt 247.40
247.60
247.70
247.90
247.80
growth rate 0.1% 0.0% 0.1% 0.0%
Equity 1,286.60
1,300.20
1,297.20
1,280.10
1,276.90
growth rate 1.1% -0.2% -1.3% -0.3%
Common Shares 0.50
0.50
0.50
0.50
0.50
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 11.10
10.70
17.70
12.50
22.90
growth rate -3.6% 65.4% -29.4% 83.2%
Cash From OA -96.70
-67.80
-7.40
-23.10
-31.90
growth rate 0.0% 0.0% 0.0% 0.0%
FCF -107.80
-78.50
-25.10
-35.60
-54.80
growth rate 0.0% 0.0% 0.0% 0.0%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 160.90
165.10
169.90
164.20
172.20
growth rate 2.6% 2.9% -3.4% 4.9%
Op.Income 14.00
15.80
14.40
-22.60
-5.20
growth rate 12.9% -8.9% -100.0% 0.0%
IBT 1.10
5.00
-9.40
-25.90
-11.30
growth rate 354.6% -100.0% 0.0% 0.0%
Net Income 35.30
4.20
-2.20
-20.30
-8.00
growth rate -88.1% -100.0% 0.0% 0.0%
Gross Profit 94.70
104.70
101.10
98.80
98.70
growth rate 10.6% -3.4% -2.3% -0.1%
R&D 10.80
10.50
10.60
10.20
9.50
growth rate -2.8% 1.0% -3.8% -6.9%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (0.00)

YOY Growth Grade:

F (8.19)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 37.61 26.89 26.03
EPS / Growth 1.22

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 4.7%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 4.7% 4.7% 4.7%
Future PE 9.44 24.36 24.36
Future EPS 1.93 1.93 1.93
Value Price
MOS %
4.51
-86.2%
11.63
-64.5%
11.63
-64.5%
MOS Price 2.25 5.82 5.82
IRT 17.21 17.21 17.21

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.